Sanofi creates diabetes mobile app for kids; Icon looks to risk-based monitoring for savings;

> Sanofi ($SNY) has created a mobile app that encourages kids with Type 1 diabetes to regularly log their blood glucose levels. Piece

> Icon ($ICLR) thinks it can cut costs by adopting data-driven, risk-based monitoring of clinical trials. Transcript

> Janssen has joined public-private drug discovery partnership Structural Genomics Consortium. Release

> Computational modeling alliance Orion Bionetworks is working with Thomson Reuters to further understanding of multiple sclerosis. News

> Personal Genome Diagnostics has partnered with MolecularMD to use next-generation sequencing for personalized medicine services. Article (reg. req.)

> BioDatomics has introduced an open source suite of next-generation sequencing data analysis software. Post

> BGI Partners is to buy 50 Ion Proton Sequencers from Life Technologies ($LIFE). Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.